Karlsson E, Molin L, Norlander B, Sjoqvist F
Br J Clin Pharmacol. 2012; 1(6):467-75.
PMID: 22454932
PMC: 1402529.
DOI: 10.1111/j.1365-2125.1974.tb01696.x.
Matthay R, Bromberg S, Putman C
Yale J Biol Med. 1980; 53(6):497-523.
PMID: 7245803
PMC: 2595934.
Schwartz J, Keefe D, Harrison D
Drugs. 1981; 21(1):23-45.
PMID: 7009136
DOI: 10.2165/00003495-198121010-00002.
van Pham C, Noguchi J, Quismorio Jr F, Haywood L
J Natl Med Assoc. 1983; 75(7):705-8.
PMID: 6887275
PMC: 2561492.
Whittingham S, Mackay I
Postgrad Med J. 1972; 48(556):95-7.
PMID: 5015123
PMC: 2495169.
DOI: 10.1136/pgmj.48.556.95.
Systemic lupus erythematosus during treatment with procainamide.
Swarbrick E, GRAY I
Br Heart J. 1972; 34(3):284-8.
PMID: 5015024
PMC: 458471.
DOI: 10.1136/hrt.34.3.284.
Procainamide-induced systemic lupus erythematosus.
Sheldon P, Williams W
Ann Rheum Dis. 1970; 29(3):236-43.
PMID: 4194201
PMC: 1031257.
DOI: 10.1136/ard.29.3.236.
Systemic lupus erythematosus syndrome induced by practolol.
Raftery E, DENMAN A
Br Med J. 1973; 2(5864):452-5.
PMID: 4145853
PMC: 1589475.
DOI: 10.1136/bmj.2.5864.452.
Occurrence, immunoglobulin pattern and specificity of antinuclear antibodies in sera of procaine amide treated patients.
Klajman A, Kimchi A, Ben-Efraim S
Clin Exp Immunol. 1970; 7(5):641-9.
PMID: 4099667
PMC: 1712881.
Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.
Muhiddin K, Turner P
Postgrad Med J. 1985; 61(718):665-77.
PMID: 3898053
PMC: 2418373.
DOI: 10.1136/pgmj.61.718.665.
Inhibition of pokeweed mitogen-induced B cell differentiation by compounds containing primary amine or hydrazine groups.
de Boccardo G, Drayer D, RUBIN A, Novogrodsky A, Reidenberg M, STENZEL K
Clin Exp Immunol. 1985; 59(1):69-76.
PMID: 3882287
PMC: 1577177.
Acetylation of procaine amide in man. A preliminary communication.
Karlsson E, Aberg G, Collste P, Molin L, Norlander B, Sjoqvist F
Eur J Clin Pharmacol. 1975; 8(1):79-81.
PMID: 1233205
DOI: 10.1007/BF00616419.
Respiratory involvement in systemic lupus erythematosus. A clinical and immunological study.
Holgate S, Glass D, Haslam P, Maini R, TURNER-WARWICK M
Clin Exp Immunol. 1976; 24(3):385-95.
PMID: 1084819
PMC: 1538527.
Clinicopathological study of a patient with procainamide-induced systemic lupus erythematosus.
Levo Y, Pick A, Avidor I, Ben-Bassat M
Ann Rheum Dis. 1976; 35(2):181-5.
PMID: 942276
PMC: 1006535.
DOI: 10.1136/ard.35.2.181.
Heterogeneity of anti-mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome.
Sayers T, Binder T, Berg P
Clin Exp Immunol. 1979; 37(1):68-75.
PMID: 487658
PMC: 1537681.
Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity.
Koch G, Lindstrom B
Eur J Clin Pharmacol. 1978; 13(4):237-40.
PMID: 352705
DOI: 10.1007/BF00716356.
Recent advances in the immunopathogenesis of systemic lupus erythematosus.
Bardana Jr E, PIROFSKY B
West J Med. 1975; 122(2):130-44.
PMID: 46657
PMC: 1130303.
